Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Non-Current Deferred Tax Liability (2016 - 2023)

Anika Therapeutics (ANIK) has disclosed Non-Current Deferred Tax Liability for 14 consecutive years, with $2.0 million as the latest value for Q3 2023.

  • Quarterly Non-Current Deferred Tax Liability fell 71.25% to $2.0 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Sep 2023, down 71.25% year-over-year, with the annual reading at $6.4 million for FY2022, 36.63% down from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2023 was $2.0 million at Anika Therapeutics, down from $3.2 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $16.0 million in Q1 2020, with the low at $2.0 million in Q3 2023.
  • Average Non-Current Deferred Tax Liability over 5 years is $8.4 million, with a median of $8.2 million recorded in 2022.
  • The sharpest move saw Non-Current Deferred Tax Liability surged 373.14% in 2020, then tumbled 71.25% in 2023.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $4.3 million in 2019, then surged by 174.65% to $11.9 million in 2020, then fell by 14.61% to $10.2 million in 2021, then plummeted by 36.63% to $6.4 million in 2022, then tumbled by 69.62% to $2.0 million in 2023.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $2.0 million, $3.2 million, and $4.1 million for Q3 2023, Q2 2023, and Q1 2023 respectively.